Celea Therapeutics Doses First Patient in Global P...
Category : Clinical Trial Update 15 July 2026Celea Therapeutics has announced that the first patient has been dosed in its global Phase 3 SURPASS...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Skyhawk Therapeutics Expands Global Phase 2/3 Tria...
Category : Clinical Trial Update 15 July 2026Skyhawk Therapeutics has received additional regulatory approvals to expand its global Phase 2/3 FAL...
Rani Therapeutics and PegBio Partner to Develop Or...
Category : Licensing/Collaboration Deal 14 July 2026Companies Team Up to Expand Oral Biologic Therapy Development Rani Therapeutics Holdings, Inc. ha...
AlloSource Launches ReConnex Pre-Sutured Tendon to...
Category : Approval/Launch 14 July 2026New Tendon Allograft Designed to Simplify ACL Surgery AlloSource has announced the launch of ReCo...
Novo Nordisk Reports Positive Long-Term Phase 3 Re...
Category : Clinical Trial Update 13 July 2026New Phase 3 Data Shows Long-Term Benefits of Denecimig Novo Nordisk has announced new Phase 3 cli...
Latest Newsletter Post
-
Skyhawk Therapeutics Expands Global..
15 July 2026
-
Celea Therapeutics Doses First Pati..
15 July 2026
-
AlloSource Launches ReConnex Pre-Su..
14 July 2026
-
Rani Therapeutics and PegBio Partne..
14 July 2026
-
OKYO Pharma Receives Positive FDA F..
13 July 2026
